CS Extension
Notes
**Note 1**: When both FIGO stage and extension detail are available, record the code with extension detail in preference to a statement of FIGO stage. **Note 2**: FIGO Stage IIIB is assigned based on tumor extension and/or regional lymph node involvement; FIGO Stage IV, NOS is assigned based on tumor extension and/or metastasis. Code CS Extension based on a physician's statement of FIGO Stage IIIB or FIGO Stage IV [NOS] only if it is known that the stage value is assigned because of tumor extension. Code a statement of FIGO Stage IIIB in CS Lymph Nodes if unknown if based on extension. Code a stage of FIGO Stage IV [NOS] in CS Mets at DX if unknown if based on extension. **Note 3**: FIGO no longer includes Stage 0 (Tis) for this site. **Note 4**: All macroscopically visible lesions, even with superficial invasion, are assigned toT1b/FIGO Stage IB. **Note 5**: Involvement of the anterior and/or posterior septum, the tissue between the vagina and bladder and between the vagina and rectum, is coded as involvement of the vaginal wall.| Code | Description | AJCC 7 T | AJCC 6 T | Summary Stage 1977 T | Summary Stage 2000 T |
|---|---|---|---|---|---|
| 000 | In situ, intraepithelial, noninvasive, preinvasive; Cancer in situ WITH endocervical gland involvement (See Note 3) |
Tis | Tis | IS | IS |
| 010 | Cervical intraepithelial neoplasia (CIN) Grade III | Tis | Tis | IS | IS |
| 110 | Minimal microscopic stromal invasion less than or equal to 3 mm in depth (measured from the base of the epithelium) and less than or equal to 7 mm in horizontal spread FIGO Stage IA1 |
T1a1 | T1a1 | L | L |
| 120 | Microscopic stromal invasion greater than 3 mm and less than or equal to 5 mm in depth, (measured from the base of the epithelium) and less than or equal to 7 mm in horizontal spread FIGO Stage IA2 |
T1a2 | T1a2 | L | L |
| 135 | Invasive carcinoma confined to cervix, microscopic size of stromal invasion and horizontal spread not specified | T1aNOS | T1aNOS | L | L |
| 140 | FIGO Stage IA [NOS] | T1aNOS | T1aNOS | L | L |
| 200 | Invasive carcinoma confined to cervix, tumor measurements greater than specified in code 120 FIGO Stage IB |
Extension Size AJCC7 | CS Extension Size Table for AJCC 6th | L | L |
| 210 | FIGO Stage IB1 | Extension Size AJCC7 | CS Extension Size Table for AJCC 6th | L | L |
| 220 | FIGO Stage IB2 | Extension Size AJCC7 | CS Extension Size Table for AJCC 6th | L | L |
| 250 | Invasive carcinoma confined to cervix, clinically visible lesion | Extension Size AJCC7 | CS Extension Size Table for AJCC 6th | L | L |
| 300 | Localized, NOS Confined to cervix uteri or uterus, NOS, except corpus uteri, NOS (Not clinically visible or unknown if clinically visible.) |
Extension Size AJCC7 | CS Extension Size Table for AJCC 6th | L | L |
| 310 | FIGO Stage I [NOS] | Extension Size AJCC7 | CS Extension Size Table for AJCC 6th | L | L |
| 350 | Corpus uteri, NOS with no other information on extension | T1NOS | T1NOS | RE | RE |
| 360 | 350 + 110 | T1a1 | T1a1 | RE | RE |
| 370 | 350 + 120 | T1a2 | T1a2 | RE | RE |
| 380 | 350 + (200 or 250) | Extension Size AJCC7 | CS Extension Size Table for AJCC 6th | RE | RE |
| 390 | 350 + (300 or 310) | Extension Size AJCC7 | CS Extension Size Table for AJCC 6th | RE | RE |
| 400 | Extension to: Cul de sac (rectouterine pouch) Upper two-thirds of vagina including fornices Vagina, NOS Vaginal wall, NOS WITHOUT parametrial invasion |
Extension Size AJCC7 | T2a | RE | RE |
| 410 | Extension beyond uterus, NOS but not to pelvic wall (excluding lower third of vagina) WITHOUT parametrial invasion |
Extension Size AJCC7 | T2a | RE | RE |
| 420 | FIGO Stage IIA1 | Extension Size AJCC7 | T2a | RE | RE |
| 440 | FIGO Stage IIA2 | Extension Size AJCC7 | T2a | RE | RE |
| 450 | FIGO Stage IIA [NOS] | Extension Size AJCC7 | T2a | RE | RE |
| 500 | Extension to: Ligament(s): Broad Cardinal Uterosacral Parametrium (paracervical soft tissue) FIGO Stage IIB |
T2b | T2b | RE | RE |
| 550 | FIGO Stage II [NOS] | Extension Size AJCC7 | T2NOS | RE | RE |
| 600 | OBSOLETE DATA RETAINED AND REVIEWED V0203 See codes 605 and 625 Extension to: Bladder wall Bladder, NOS excluding mucosa Bullous edema of bladder mucosa Lower third of vagina Rectal wall Rectum, NOS excluding mucosa FIGO Stage IIIA |
T3a | T3a | RE | RE |
| 605 | Extension to: Bladder wall Bladder, NOS excluding mucosa Bullous edema of bladder mucosa Lower third of vagina Rectal wall Rectum, NOS excluding mucosa |
T3a | T3a | RE | RE |
| 620 | OBSOLETE DATA RETAINED AND REVIEWED V0203 See codes 622 and 625 Extension to: Ureter, intra- and extramural Vulva FIGO Stage IIIA |
T3a | T3a | D | RE |
| 622 | Extension to: Ureter, intra- and extramural Vulva |
T3a | T3a | D | RE |
| 625 | FIGO Stage IIIA | T3a | T3a | RE | RE |
| 630 | OBSOLETE DATA RETAINED AND REVIEWED V0203 See codes 635 and 660 Tumor causes hydronephrosis or nonfunctioning kidney FIGO Stage IIIB |
T3b | T3b | RE | RE |
| 635 | Tumor causes hydronephrosis or nonfunctioning kidney | T3b | T3b | RE | RE |
| 650 | OBSOLETE DATA RETAINED AND REVIEWED V0203 See codes 655 and 660 Extension to pelvic wall(s) (Described clinically as "frozen pelvis", NOS) FIGO Stage IIIB |
T3b | T3b | D | RE |
| 655 | Extension to pelvic wall(s) Described clinically as frozen pelvis |
T3b | T3b | D | RE |
| 660 | FIGO Stage IIIB based on extension | T3b | T3b | RE | RE |
| 680 | OBSOLETE DATA RETAINED AND REVIEWED V0203 See codes 685 and 690 Extension to: Fallopian tube(s) Ovary(ies) Urethra FIGO Stage III [NOS] |
T3NOS | T3NOS | D | RE |
| 685 | Extension to: Fallopian tube(s) Ovary(ies) Urethra |
T3NOS | T3NOS | D | RE |
| 690 | FIGO Stage III [NOS] | T3NOS | T3NOS | D | RE |
| 700 | Extension to rectal or bladder mucosa (Note: for bullous edema of bladder mucosa, see code 600-605) |
T4 | T4 | D | D |
| 800 | Further contiguous extension beyond true pelvis Sigmoid colon Small intestine |
T4 | T4 | D | D |
| 850 | FIGO Stage IVA | T4 | T4 | D | D |
| 860 | FIGO Stage IV [NOS] based on extension | T4 | T4 | D | D |
| 950 | No evidence of primary tumor | T0 | T0 | U | U |
| 999 | Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record |
TX | TX | U | U |